FDA approves Johnson & Johnson nasal spray for depression
The Food and Drug Administration (FDA) has approved a new form of treatment for treatment-resistant depressionwhich could represent a key alternative for many patients who do not respond to conventional treatments. This is Spravato, a nasal spray developed by Johnson & Johnson, which can be used independently, without the need to be accompanied by an … Read more